Clinical Features of 29 Patients with Hereditary Tyrosinemia I in Western Turkey
Articles > Article · 2018
Authors: Havva YAZICI, Esra Er, Ebru CANDA, Sara HABİF, Sema KALKAN UÇAR, Mahmut ÇOKER
JOURNAL OF PEDIATRIC RESEARCH, Journal Indexed in SCI Expanded, International, 2018, vol 5, pp 1-6
DOI: 10.4274/jpr.00710
Summary
Aim: The aim of this study was to investigate the long-term outcome of hereditary tyrosinemia Type I (HTI) patients treated with 2-(2-nitro-4-trifluoromethylbenzoyl)-1-1,3-cyclohexanedione (NTBC) to increase knowledge about the clinical outcome in these patients. We want to mention that the patients with HTI have heterogeneous clinic Early diagnosis and early treatment important to prevent the complications.